An enolase inhibitor for the targeted treatment of ENO1-deleted cancers
Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi, Victoria C. Yan, Yasaman Barekatain, Sunada Khadka, Jeffrey J. Ackroyd, Dimitra K. Georgiou, Cong-Dat Pham, Kenisha Arthur, David S. Maxwell, Zhenghong Peng, Paul G. Leonard, Barbara Czakó, Federica Pisaneschi, Pijus K. Mandal, Yuting Sun, Rafał Zieliński, Susana Castro-Pando, Xiaobo Wang, Theresa Tran, Quanyu Xu, Qi Wu, Yongying Jiang, Zhijun Kang, John M. Asara, Waldemar Priebe, William G. Bornmann, Joseph R. Marszalek, Ronald A. DePinho, Florian L. Müller
Topics & Concepts
EnolaseCancer researchGlycolysisIn vivoBiologyGliomaGene isoformCancerCollateral damageEnzymeCancer cellBiochemistryImmunologyImmunohistochemistryGeneGeneticsCriminologySociologyATP Synthase and ATPases ResearchCancer, Hypoxia, and MetabolismS100 Proteins and Annexins